NFKB1 and cancer: The miR-146 family, which includes miR-146a and miR-146b, modulates immune and inflammatory responses (Paterson and Kriegel, 2017) and exhibits cancer-suppressive effects in pathways such as those involving platelet-derived growth factor and NF-κB (Liu et al., 2015).